Valuation (72%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 14.34 | 13.53 |
| PEG Ratio (TTM) | 0.39 | 2.90 |
| P/S Ratio (TTM) | 0.60 | 1.60 |
| P/B Ratio (TTM) | 0.91 | 2.76 |
| P/FCF Ratio (TTM) | 3.70 | 7.41 |
| Price to 5YR AVG Earnings Ratio | -110.84 | 20.46 |
| Price to 5YR AVG FCF Ratio | 13.97 | 11.84 |
Profitability (15%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.41% | 4.45% |
| ROE (TTM) | 6.72% | 21.63% |
| Net Profit Margin (TTM) | 4.15% | 11.44% |
| ROIC 5YR AVG | -1.25% | 10.32% |
Growth (42%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 217.07% | -245.91% | -223.14% |
| Revenue | 4.22% | 0.33% | 0.93% |
| Net Income | 219.50% | -245.13% | -222.87% |
| Cash Flow | 24.24% | -32.82% | 2,725.05% |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | N/A | 21.95 |
| Quick Ratio (TTM) | N/A | 21.95 |
| D/E Ratio (TTM) | 0.15 | 0.38 |
| Interest Coverage (TTM) | 42.08 | 19.77 |
| Piotroski F-Score | 4 | 7 |
| Altman Z-Score | 1.07 | 1.64 |
| LTL to 5YR AVG FCF | 0.97 | 1.40 |
| Shares Outstanding Growth 5YR AVG | 0.14% | -2.24% |